−0.1610 USD
−5.32 M USD
0.00 USD
34.43 M
About Cell Source, Inc.
Sector
Industry
CEO
Itamar Shimrat
Website
Headquarters
New York
Founded
2012
FIGI
BBG0046WCTF1
Cell Source, Inc. is a biotechnology company, which focuses on developing cell therapy treatments based on the management of immune tolerance. Its Veto Cell immune system management technology is an immune tolerance biotechnology that enables the selective blocking of immune responses. The Veto Cell platform roadmap consists of two main programs: VETO CAR-T (with and without HSCT) and Veto Cell Organ Transplantation. The company was founded on June 6, 2012 and is headquartered in New York, NY.
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
−1.60 M
−1.20 M
−800.00 K
−400.00 K
0.00
Revenue
Net income
Net margin %
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
−1.60 M
−1.20 M
−800.00 K
−400.00 K
0.00
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
−1.60 M
−1.20 M
−800.00 K
−400.00 K
0.00
No news here
Looks like there's nothing to report right now
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of CLCS is 0.2700 USD — it has decreased by −10.00% in the past 24 hours. Watch Cell Source, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Cell Source, Inc. stocks are traded under the ticker CLCS.
CLCS stock has risen by 7.96% compared to the previous week, the month change is a −12.90% fall, over the last year Cell Source, Inc. has showed a 134.90 K% increase.
CLCS reached its all-time high on Jan 6, 2021 with the price of 2.5500 USD, and its all-time low was 0.0002 USD and was reached on Apr 19, 2024. View more price dynamics on CLCS chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
CLCS stock is 28.71% volatile and has beta coefficient of −367.85. Track Cell Source, Inc. stock price on the chart and check out the list of the most volatile stocks — is Cell Source, Inc. there?
Today Cell Source, Inc. has the market capitalization of 13.04 M, it has decreased by −6.56% over the last week.
Yes, you can track Cell Source, Inc. financials in yearly and quarterly reports right on TradingView.
CLCS net income for the last quarter is −1.42 M USD, while the quarter before that showed −1.49 M USD of net income which accounts for 4.81% change. Track more Cell Source, Inc. financial stats to get the full picture.
No, CLCS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CLCS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Cell Source, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Cell Source, Inc. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Cell Source, Inc. stock shows the sell signal. See more of Cell Source, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.